Displaying 10 - 18 of 1066
Title Application Due Date Award Amount Sort descending Description
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Varies

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country. This FOA can support training for conducting research in a broad range of HIV research areas across HIV prevention, treatment, care, and quality of life continuum. This includes basic, epidemiologic…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339720

Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Varies

The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339829

Pathogenic Mechanisms influencing Blood Brain Barrier function in HIV and Substance Use Disorders (R01 Clinical Trial Optional) Varies

The blood brain barrier (BBB) is a target of both the HIV virus and substances of abuse. It is a site of entry for HIV infected monocytes and macrophages that can traverse the BBB either paracellularly or transcellularly. HIV viral proteins can also attack astrocytes and tight junctions of BBB directly and compromise its integrity, resulting in the crossing of the virus, as well as abused substances, into the brain. Meanwhile, many substances of abuse cause BBB dysfunction. Because BBB…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339850

Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Varies

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=340173

Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Varies

The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=340174

NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) Varies

The goal of this funding opportunity announcement is to support meritorious research projects that involve secondary statistical analyses of existing dental, oral or craniofacial database resources, or that develop needed statistical methodology for analyzing existing dental, oral or craniofacial databases.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=340195
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Varies

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a…https://www.grants.gov/web/grants/view-opportunity.html?oppId=340214

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Varies

The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a…https://www.grants.gov/web/grants/view-opportunity.html?oppId=340228

CWMD: Academic Research Initiative (ARI) Varies

The CWMD ARI Program seeks novel cross-cutting research that will enhance the nation’s capabilities to detect and prevent the illicit entry, transport, assembly, or potential use of unauthorized CBRN materials, devices, or agents within the United States, and otherwise help protect against an attack using such materials, devices, or agents. The CWMD ARI Program aligns with and supports the FY2020-24 DHS Strategic Plan, Goal 1: Counter Terrorism and Homeland Security Threats, and…https://www.grants.gov/web/grants/view-opportunity.html?oppId=339987